Home › Companies › BioLife Solutions, Inc. › 2025-2026

BioLife Solutions, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and BioLife Solutions, Inc.’s Form 8-K, filed 2025-08-21 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 12Reported items
  • 262Asset managers
  • 2,518Fund votes
  • 2025-08-20Main meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore BioLife Solutions, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by BioLife Solutions, Inc.

These tallies are BioLife Solutions, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-08-21 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BioLife Solutions, Inc. — official shareholder meeting results, meeting held 2025-08-20
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Roderick de Greef 39,608,298---- 940,3902,514,349 Majority: yes
Elect Director: Catherine Coste 40,460,424---- 88,2642,514,349 Majority: yes
Elect Director: Amy DuRoss 39,902,654---- 646,0342,514,349 Majority: yes
Elect Director: Rachel Ellingson 20,731,406---- 19,817,2822,514,349 Majority: yes
Elect Director: Joydeep Goswami 23,021,878---- 17,526,8102,514,349 Majority: yes
Elect Director: Tony Hunt 39,264,968---- 1,283,7202,514,349 Majority: yes
Elect Director: Timothy Moore 40,089,287---- 459,4012,514,349 Majority: yes
Proposal 2: Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. The compensation of the Company's named executive officers by a non-binding, advisory vote was approved. The voting results were as follows: 38,403,8562,060,35284,480 --2,514,349 Majority: yes
Proposal 3: Ratification of the appointment by the Audit Committee of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The ratification of the appointment by the Audit Committee of 43,024,01911,16927,849 ---- Majority: yes

Source: BioLife Solutions, Inc., Form 8-K, filed with the SEC on 2025-08-21 — read the filing on EDGAR.

How asset managers voted at the BioLife Solutions, Inc. 2025-2026 meetings

Each item below shows how the 262 asset managers that disclosed a BioLife Solutions, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BioLife Solutions, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-08-20.

Combines 6 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 38,403,856AGAINST: 2,060,352

BioLife Solutions, Inc.’s own tally for this item (“Proposal 2: Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. The compensation of the Company's named executive officers by a non-binding, advisory vote was approv”): 38,403,856 for, 2,060,352 against, per its Form 8-K filed 2025-08-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,104,888 outstanding shares: 83% for, 4% against (88% of the company cast a for/against vote).

The 254 asset managers below cast 94% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 94%
FOR: 93.7%AGAINST: 6.3%NOT VOTED: 0.0%
Largest asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price7,431,7180 00For
Casdin Capital, LLC6,875,4810 00For
Invesco4,904,8240 00For
BlackRock3,243,6596,293 00For
Vanguard2,871,2012,093 00For
FRED ALGER MANAGEMENT, LLC01,277,349 00Against
State Street1,234,156329 00For
Voya960,942225,752 00For
ALGER FUNDS01,176,523 00Against
MASSACHUSETTS FINANCIAL SERVICES CO /MA/1,102,1300 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
GEODE CAPITAL MANAGEMENT, LLC888,0790 00For
Fidelity804,0030 00For
Jackson National758,8850 00For
GENEVA CAPITAL MANAGEMENT LLC727,3570 00For
Charles Schwab643,0830 00For
Royce589,1650 00For
PALISADE CAPITAL MANAGEMENT, LP560,4670 00For
Granahan Investment Management, LLC522,5750 00For
EAGLE ASSET MANAGEMENT INC485,4490 00For
ROCKEFELLER & CO. LLC433,0360 00For
Allspring427,3970 00For
CRAMER ROSENTHAL MCGLYNN LLC392,1340 00For
Northern Trust365,6710 00For

Showing the 25 largest of 254 asset managers. See all 254 in the interactive database.

2. To ratify the appointment by the Board of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-08-20.

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 43,024,019AGAINST: 11,169

BioLife Solutions, Inc.’s own tally for this item (“Proposal 3: Ratification of the appointment by the Audit Committee of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The ratification of th”): 43,024,019 for, 11,169 against, per its Form 8-K filed 2025-08-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,104,888 outstanding shares: 93% for, 0.1% against (93% of the company cast a for/against vote).

The 73 asset managers below cast 100% of the shares they voted on this item FOR (20,555,728 for, 0 against).

FOR 100%
FOR: 20,555,728 (100.0%)
Largest asset managers voting on “To ratify the appointment by the Board of Grant Thornton LLP as the Company's independent registered public ac” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,764,8120 00For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,8970 00For
Voya480,4710 00For
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Brighthouse306,1830 00For
Nationwide305,8750 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica122,9340 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

3. Election of Directors: Amy DuRoss

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-20.

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 39,902,654WITHHELD: 646,034

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Amy DuRoss”): 39,902,654 for, 646,034 withheld, per its Form 8-K filed 2025-08-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,104,888 outstanding shares: 87% for, 1% withheld (88% of the company cast a for/withheld vote).

The 71 asset managers below cast 100% of the shares they voted on this item FOR (20,501,919 for, 0 against).

FOR 99.8%
FOR: 20,501,919 (99.8%)ABSTAIN: 32,210 (0.2%)
Largest asset managers voting on “Election of Directors: Amy DuRoss” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,758,8950 5,9160For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,2030 6940For
Voya480,4710 00For
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Brighthouse306,1830 00For
Nationwide305,8750 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica122,9340 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

4. Election of Directors: Cathy Coste

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-20.

Combines 6 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 40,460,424WITHHELD: 88,264

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Catherine Coste”): 40,460,424 for, 88,264 withheld, per its Form 8-K filed 2025-08-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,104,888 outstanding shares: 88% for, 0.2% withheld (88% of the company cast a for/withheld vote).

The 71 asset managers below cast 100% of the shares they voted on this item FOR (20,534,129 for, 0 against).

FOR 100%
FOR: 20,534,129 (100.0%)
Largest asset managers voting on “Election of Directors: Cathy Coste” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,764,8120 00For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,8970 00For
Voya480,4710 00For
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Brighthouse306,1830 00For
Nationwide305,8750 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica122,9340 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

5. Election of Directors: Joydeep Goswami

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-20.

Combines 6 wordings of this item as funds reported it.

57% Majority: yes · of votes cast

FOR 57%WITHHELD 43%
FOR: 23,021,878WITHHELD: 17,526,810

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Joydeep Goswami”): 23,021,878 for, 17,526,810 withheld, per its Form 8-K filed 2025-08-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,104,888 outstanding shares: 49.9% for, 38% withheld (88% of the company cast a for/withheld vote).

The 71 asset managers below cast 100% of the shares they voted on this item FOR (11,274,157 for, 0 against).

FOR 54.9%ABSTAIN 45.1%
FOR: 11,274,157 (54.9%)ABSTAIN: 9,259,972 (45.1%)
Largest asset managers voting on “Election of Directors: Joydeep Goswami” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price00 3,023,8000Abstain
Vanguard2,758,8700 5,9410For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS00 1,176,5230Abstain
Columbia Threadneedle00 1,067,4060Abstain
MFS00 1,005,9870Abstain
Fidelity800,7880 00For
Jackson National596,4300 162,4550For
Royce587,2460 00For
State Street4970 538,4000Abstain
Voya00 480,4710Abstain
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Brighthouse292,7120 13,4710For
Nationwide302,3790 3,4960For
Charles Schwab299,8050 00For
MoA Funds Corp00 283,4220Abstain
Dimensional00 254,5800Abstain
Allspring00 171,8920Abstain
AIG/SunAmerica00 122,9340Abstain
Victory Capital00 113,7480Abstain
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life11,3850 96,1430Abstain
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

6. Election of Directors: Rachel Ellingson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-20.

Combines 6 wordings of this item as funds reported it.

51.1% Majority: yes · of votes cast

FOR 51.1%WITHHELD 48.9%
FOR: 20,731,406WITHHELD: 19,817,282

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Rachel Ellingson”): 20,731,406 for, 19,817,282 withheld, per its Form 8-K filed 2025-08-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,104,888 outstanding shares: 45% for, 43% withheld (88% of the company cast a for/withheld vote).

The 71 asset managers below cast 100% of the shares they voted on this item FOR (8,599,334 for, 0 against).

FOR 42%ABSTAIN 58%
FOR: 8,599,334 (41.9%)ABSTAIN: 11,934,795 (58.1%)
Largest asset managers voting on “Election of Directors: Rachel Ellingson” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price00 3,023,8000Abstain
Vanguard2,760,9620 3,8500For
BlackRock2,423,4940 00For
Invesco00 1,910,6560Abstain
ALGER FUNDS00 1,176,5230Abstain
Columbia Threadneedle00 1,067,4060Abstain
MFS00 1,005,9870Abstain
Fidelity800,7880 00For
Jackson National00 758,8850Abstain
Royce587,2460 00For
State Street4970 538,4000Abstain
Voya00 480,4710Abstain
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Brighthouse00 306,1830Abstain
Nationwide302,3790 3,4960For
Charles Schwab299,8050 00For
MoA Funds Corp00 283,4220Abstain
Dimensional00 254,5800Abstain
Allspring00 171,8920Abstain
AIG/SunAmerica00 122,9340Abstain
Victory Capital00 113,7480Abstain
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life11,3850 96,1430Abstain
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

7. Election of Directors: Timothy L. Moore

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-20.

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 40,089,287WITHHELD: 459,401

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Timothy Moore”): 40,089,287 for, 459,401 withheld, per its Form 8-K filed 2025-08-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,104,888 outstanding shares: 87% for, 1.0% withheld (88% of the company cast a for/withheld vote).

The 71 asset managers below cast 100% of the shares they voted on this item FOR (20,507,656 for, 0 against).

FOR 99.8%
FOR: 20,507,656 (99.9%)ABSTAIN: 26,473 (0.1%)
Largest asset managers voting on “Election of Directors: Timothy L. Moore” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,762,7210 2,0910For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,8970 00For
Voya480,4710 00For
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Brighthouse306,1830 00For
Nationwide305,8750 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica122,9340 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

8. Election of Directors: Tony Hunt

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-20.

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 39,264,968WITHHELD: 1,283,720

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Tony Hunt”): 39,264,968 for, 1,283,720 withheld, per its Form 8-K filed 2025-08-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,104,888 outstanding shares: 85% for, 3% withheld (88% of the company cast a for/withheld vote).

The 71 asset managers below cast 100% of the shares they voted on this item FOR (20,050,933 for, 0 against).

FOR 98%
FOR: 20,050,933 (97.6%)ABSTAIN: 483,196 (2.4%)
Largest asset managers voting on “Election of Directors: Tony Hunt” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,764,8100 20For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,8970 00For
Voya00 480,4710Abstain
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Brighthouse306,1830 00For
Nationwide304,8990 9760For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica122,9340 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

9. Election of Directors: Roderick de Greef

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-08-20.

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 39,608,298WITHHELD: 940,390

BioLife Solutions, Inc.’s own tally for this item (“Elect Director: Roderick de Greef”): 39,608,298 for, 940,390 withheld, per its Form 8-K filed 2025-08-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,104,888 outstanding shares: 86% for, 2% withheld (88% of the company cast a for/withheld vote).

The 70 asset managers below cast 100% of the shares they voted on this item FOR (20,040,117 for, 0 against).

FOR 98%
FOR: 20,040,117 (97.6%)ABSTAIN: 483,922 (2.4%)
Largest asset managers voting on “Election of Directors: Roderick de Greef” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,023,8000 00For
Vanguard2,764,8100 20For
BlackRock2,423,4940 00For
Invesco1,910,6560 00For
ALGER FUNDS1,176,5230 00For
Columbia Threadneedle1,067,4060 00For
MFS1,005,9870 00For
Fidelity800,7880 00For
Jackson National758,8850 00For
Royce587,2460 00For
State Street538,8800 170For
Voya00 480,4710Abstain
Bridge Builder Trust337,3940 00For
CRM Mutual Fund Trust322,5850 00For
Brighthouse306,1830 00For
Nationwide305,8750 00For
Charles Schwab299,8050 00For
MoA Funds Corp283,4220 00For
Dimensional254,5800 00For
Allspring171,8920 00For
AIG/SunAmerica122,9340 00For
Victory Capital113,7480 00For
TRUST FOR PROFESSIONAL MANAGERS112,2300 00For
Pacific Life107,5280 00For
OPTIMUM FUND TRUST103,3420 00For

Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.

10. As per the Issuer, this meeting is no longer taking place.

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2026-06-17; no official results are on file for this meeting.

98% fund support · no official result

FOR 37%1 YEAR 63%

The 13 asset managers below cast 98% of the shares they voted on this item FOR (67,457 for, 1,334 against).

FOR: 67,457 (36.5%)AGAINST: 1,334 (0.7%)1 YEAR: 115,977 (62.8%)
Largest asset managers voting on “As per the Issuer, this meeting is no longer taking place.” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ZACKS INVESTMENT MANAGEMENT00 001 Year
Zacks Trust62,5530 00For
SARATOGA ADVANTAGE TRUST3,4770 00For
First Trust01,334 00Against
Guardian Wealth Advisors, LLC1,1900 00For
Boltwood Capital Management1340 00For
Wealth Architects, LLC800 00For
Waverly Advisors, LLC140 00For
Performance Wealth Partners, LLC90 00For
GAMMA Investing LLC00 00--
Granite Investment Partners, LLC00 00--
STEPHENS INC /AR/00 00--
Vanguard00 00--

11. DIRECTOR

DIRECTOR ELECTIONS

Meeting held 2026-06-17; no official results are on file for this meeting.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (66,030 for, 0 against).

FOR: 66,030 (100.0%)
Largest asset managers voting on “DIRECTOR” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Zacks Trust62,5530 00For
SARATOGA ADVANTAGE TRUST3,4770 00For

12. DIRECTOR

DIRECTOR ELECTIONS

Meeting held 2025-08-20.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (21,599 for, 0 against).

FOR: 21,599 (100.0%)
Largest asset managers voting on “DIRECTOR” at BioLife Solutions, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Zacks Trust19,8410 00For
SARATOGA ADVANTAGE TRUST1,7580 00For

Largest BioLife Solutions, Inc. shareholders voting in 2025-2026

Ranked by the number of BioLife Solutions, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 46,104,888 shares outstanding at the time of that meeting.

Top BioLife Solutions, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1T. Rowe Price 16.12%
2Casdin Capital, LLC 14.91%
3Invesco 10.64%
4BlackRock 7.05%
5Vanguard 6.23%
6FRED ALGER MANAGEMENT, LLC 2.77%
7State Street 2.68%
8Voya 2.57%
9ALGER FUNDS 2.55%
10MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.39%

Reported BioLife Solutions, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

BioLife Solutions, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 13.23% 13F
Casdin Capital, LLC 10.32% 13G
T. Rowe Price Investment Management, Inc. 7.95% 13G
Vanguard Group 6.70% 13F
Integrated Core Strategies (US) LLC 5.22% DEF14A
Invesco 5.09% 13F
State Street 3.42% 13F
FMR (Fidelity) 3.19% 13F
Dimensional Fund Advisors 2.25% 13F
Geode Capital 2.11% 13F

Percentages above are of 46,104,888 shares outstanding, as reported by BioLife Solutions, Inc. on its Form 10-Q dated 2024-06-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BioLife Solutions, Inc.’s 10-Q dated 2024-06-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At BioLife Solutions, Inc.'s 2 shareholder meetings in the 2025-2026 proxy season (held 2025-08-20 and 2026-06-17), 262 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,518 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item of the season, voted at the meeting held 2025-08-20 — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BioLife Solutions, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-08-21.

BioLife Solutions, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).